Regenxbio (RGNX) Debt Ratio (2014)

Regenxbio's (RGNX) quarterly Debt Ratio came in at 0.41 in Q4 2014.

Regenxbio (RGNX) Debt Ratio (2014) Analysis & Trends

Regenxbio's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.41 for Q4 2014.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.41 in Q4 2014; TTM through Dec 2014 was 0.41, a N/A change from a year earlier, with the FY2014 full-year figure at 0.41, changed N/A from the prior year.
Debt Ratio was little changed at 0.41 in Q4 2014 per RGNX's latest filing.
Across five years, Debt Ratio topped out at 0.41 in Q4 2014 and bottomed at 0.41 in Q4 2014.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	1.41
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.11
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.05
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Regenxbio	528.62 Mn	298.55 Mn	21.22 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2014	0.41